Table 2.
Clinical characteristics of patients.
| Phenotypes | Non-AF |
AF |
Total |
p-Value |
|---|---|---|---|---|
| n = 5 | n = 6 | n = 11 | ||
| Age (years) | 72.0 ± 4.1 | 66.0 ± 7.2 | 68.7 ± 2.0 | NS |
| Female, n (%) | 1(20.0) | 3(50.0) | 4(36.4) | NS |
| Drinking history, n (%) | 1(20.0) | 4(66.7) | 5(45.5) | NS |
| Smoking history, n (%) | 3(60.1) | 2(33.4) | 5(45.5) | NS |
| LA diameter (mm) | 50.6 ± 3.0 | 54.3 ± 10.2 | 52.6 ± 2.3 | NS |
| Dyslipidemia, n (%) | 2(40.0) | 1(16.7) | 3(27.3) | NS |
| History of CAD, n (%) | 2(40.0) | 2(33.4) | 4(36.4) | NS |
| Diabetes mellitus, n (%) | 0(0.0) | 0(0.0) | 0(0.0) | NS |
| Heart failure, n (%) | 3(60.1) | 5(83.3) | 8(72.7) | NS |
| Hypertension, n (%) | 3(60.2) | 2(33.4) | 5(45.5) | NS |
| HCM, n (%) | 0(0.0) | 1(16.7) | 1(9.1) | NS |
| CKD, n (%) | 1(20.0) | 0(0.0) | 1(9.1) | NS |
| COPD, n (%) | 1(20.0) | 0(0.0) | 1(9.1) | NS |
LA diameter, left atrial diameter; BNP, B-type natriuretic peptide; MVD, mitral valve disease; CAD, coronary atherosclerotic heart disease; HCM, hypertrophic cardiac myopathy; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease.